AN2 Therapeutics Inc (ANTX)
2.265
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
2.265
0.00 (0.00%)
After-Hours: 20:00
AN2 Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Revance Therapeutics Inc | -4.356 |
Viking Therapeutics Inc | -- |
VYNE Therapeutics Inc | 0.00 |
Aquestive Therapeutics Inc | -0.7929 |
Humacyte Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 121.26M |
Total Liabilities (Quarterly) | 10.66M |
Shareholders Equity (Quarterly) | 110.60M |